Search alternatives:
026 decrease » a decrease (Expand Search), nn decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
0 decrease » a decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
g decrease » a decrease (Expand Search), gy decreased (Expand Search), _ decreased (Expand Search)
09 0 » 0 0 (Expand Search), 01 0 (Expand Search), 05 0 (Expand Search)
5 g » 5 mg (Expand Search)
026 decrease » a decrease (Expand Search), nn decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
0 decrease » a decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
g decrease » a decrease (Expand Search), gy decreased (Expand Search), _ decreased (Expand Search)
09 0 » 0 0 (Expand Search), 01 0 (Expand Search), 05 0 (Expand Search)
5 g » 5 mg (Expand Search)
-
1
-
2
-
3
GSK343 decreased tumor stemness.
Published 2021“…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”
-
4
-
5
VHFD becomes dehydrated, decreasing its palatability.
Published 2023“…The dotted line indicates 50% chance. All values represent AVG ± SEM. *p < 0.05, *p < 0.01. d = day, R = Rehydrated.…”
-
6
Supplementary Material for: Cardiac Troponin Is Elevated in Patients with Thyrotoxicosis and Decreases as Thyroid Function Improves and Brain Natriuretic Peptide Levels Decrease
Published 2020“…A decrease in FT<sub>4</sub> in the first 3 months was weakly correlated with decreases in hsTnI (ρ = 0.32, <i>p</i> = 0.0004) and BNP (ρ = 0.32; <i>p</i> = 0.0003). …”
-
7
-
8
-
9
-
10
-
11
GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age.
Published 2021“…GCase activity measured by 4-MU in brain (A) measured as follows: WT 4mo 27.63±0.68, HOM 4mo 2.53±0.07, WT 8mo 27.65±0.69, HOM 8mo 3.01±0.20, WT 12 mo 27.49±0.46, HOM 12mo 3.15±0.26. GCase activity measured by 4-MU in liver (B) measured as follows: WT 4mo 93.69±7.16, HOM 4mo 3.90±0.21, WT 8mo 112.40±6.84, HOM 8mo 1.50±0.19, WT 12 mo 96.79±7.44, HOM 12mo 3.50±0.58. …”
-
12
Juvenile demyelination leads to a decrease in axonal complexity of PFC PV interneurons.
Published 2025“…Example image of a biocytin-labeled PFC PV interneuron from a control mouse (left) and from cuprizone-treated mouse (right); scale bar: 50 µm. <b>G</b>. <i>Left.</i> Total proximal axonal length is decreased in cuprizone-treated PFC PV interneurons compared with control cells (<i>t test; n = 10/9 cells per group, **p < 0.01</i>)<i>. …”
-
13
Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50.
Published 2024“…(A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
-
14
-
15
-
16
Juvenile demyelination leads to a substantial decrease in potassium currents in PV interneurons of the PFC.
Published 2025“…Scale: 500 pA, 100 ms. <b>B</b>. I–V curves showing a significant decrease in Kv amplitude in PV interneurons from mice that underwent juvenile demyelination. …”
-
17
Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.
Published 2023“…<p>Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.…”
-
18
-
19
-
20